Biomedical Research Foundation

Biomedical Research Foundation of Central Arkansas, a tax-exempt nonprofit foundation headquartered in Little Rock, Arkansas, operates as a federal grant recipient and sub-recipient conducting biomedical and translational research on aging, veteran health, and epigenetics for the National Institutes of Health (NIH), the Defense Health Agency (DHA), and the Food and Drug Administration (FDA). The foundation holds 26% of its recent awards as a prime grant recipient and 74% as a sub-recipient working under larger academic and research institutions, concentrating its work in clinical and translational research rather than contracts.

The foundation's customer base centers on HHS research agencies. NIH programs dominate the portfolio: the National Center for Advancing Translational Sciences (NCATS) and the National Institute on Aging (NIA) together account for nine awards across the top customers by count. The Defense Health Agency contributes four awards, primarily on veteran health outcomes and exposure research. The FDA holds two awards with a combined potential value of $343 thousand. Across all 23 recent awards (prime and sub combined), the foundation reports $343 thousand in combined potential value but $6.9 million in combined dollars obligated, indicating that dollars realized substantially exceed published potential values — a signal typical of mature, executed research grants where invoice-based obligations dwarf initial estimates.

The foundation's prime grant work includes a $720,513 five-year project grant from the National Institute on Aging (awarded August 15, 2026, through July 31, 2031) conducting a randomized, double-blinded, placebo-controlled trial evaluating discontinuation of low-dose levothyroxine therapy in older adults with subclinical hypothyroidism, and a project grant from the Defense Health Agency (awarded May 1, 2022, through April 30, 2027) investigating DNA methylation markers associated with burn pit exposure and adverse health outcomes in veterans. As a sub-recipient, the foundation participates in research networks anchored by the University of Arkansas for Medical Sciences, Boston University, Johns Hopkins University, UCLA, and the Veterans Medical Research Foundation, contributing investigator effort, site management, and laboratory services (DNA methylation and genotyping assays, pharmacogenomics analysis) to multi-institution consortia on aging, eating disorders, Alzheimer's disease, and translational research expansion.

Activity has accelerated from one award in 2022 to five in 2024, with only one award (combined potential value not specified) completing within the next twenty-four months. The foundation operates entirely outside contract vehicles; all work flows through federal grant programs under CFDA 93.866 (Aging Research) and related NIH and DHA statutory grant authority.